Xov xwm

T hlwb ua lub luag haujlwm tseem ceeb hauv peb lub cev tiv thaiv kab mob, thiab T cell kho tau tawg hauv kev kho cov kab mob nyuaj xws li mob qog noj ntshav thiab kab mob autoimmune. Ib kauj ruam tseem ceeb hauv T cell kho,T-cell activation, ncaj qha cuam tshuam cov txiaj ntsig kho mob. Yog vim li cas peb zoo siab los qhia pebActCel T Cell Activation Reagent (Cat. No. TL-6001-1000)- tsim los rau kev ua siab mos, ua kom muaj txiaj ntsig zoo los txhawb kev ua haujlwm siab ntawm tes thiab nthuav dav.

Cov yam ntxwv tseem ceeb
✔️ Muaj kev nyab xeeb thiab siv tau: Kev ua kom maj mam ua kom muaj zog ntawm tes
✔️ Siv tau yooj yim: Npaj-rau-siv hom
✔️ Tus Nqi Ua Haujlwm: Txhim khu kev ua haujlwm nrog tus nqi sib tw

Cov kab mob autoimmune yog qhov nyuaj rau kev noj qab haus huv thoob ntiaj teb, cuam tshuam ze li 10% ntawm cov pejxeem. Tab sis yuav ua li cas yog tias kuv tau hais rau koj tias muaj peev xwm ua tiav hauv kev kho cov mob no?

Peb zoo siab los qhia peb cov webinar tshiab, "To taub Autoimmune CAR-T Therapy," featuring Dr. Allan Zhang. Nyob rau hauv qhov kev pom zoo no, Dr. Zhang tshawb txog qhov kev txiav txim siab ntawm CAR-T thev naus laus zis thiab nws daim ntawv thov hauv cov kab mob autoimmune, muab kev cia siab rau kev tso tshuaj tsis muaj tshuaj.

Peb zoo siab tshaj tawm tias T&L Biotechnology yuav koom nrog 31st Ib Xyoo ESGCT Congress, ib qho kev tshwm sim tseem ceeb hauv kev kho noob caj noob ces thiab kev kho ntawm tes.

Tsis txhob plam lub sijhawm no los ua ib feem ntawm qhov kev hloov pauv. Yog xav paub ntxiv lossis teeb tsa lub rooj sib tham, thov hu rau peb ncaj qha. Peb zoo siab tos txais koj tuaj rau ntawm peb lub rooj muag khoom thiab sib tham txog yuav ua li cas T&L Biotechnology tuaj yeem ua tus khub tseem ceeb hauv koj txoj kev taug kev.

Pom koj hauv Rome!

Raws li ib txoj hauv kev tshiab ntawm kev kho mob qog noj ntshav ib leeg, CAR-T cell therapy tau pom tias muaj peev xwm kho tau zoo. Txawm li cas los xij, kev lag luam kev lag luam txhais tau tias muaj kev cov nyom tshiab. Piv nrog rau cov tshuaj ib txwm muaj, "nyob" biopharmaceuticals muaj ntau dua qhov tsis meej, muaj teeb meem ...

Cov kab mob ntuj tsim tawm los ntawm cov pob txha pob txha lymphoid qia hlwb thiab yog cov tshuaj tiv thaiv kab mob hauv lub cev. Lawv muaj npe tom qab lawv tsis yog tshwj xeeb cytotoxicity. Kev tua ntawm NK hlwb tsis txwv los ntawm MHC thiab tsis nyob ntawm cov tshuaj tiv thaiv, yog li nws yog hu ua natural killing act.

Nyob rau hauv xyoo tas los no, qia hlwb tau dhau los ua dav siv hauv kev siv tshuaj kho mob. Txawm li cas los xij, qhov kev faib ua feem thiab qhov ntau ntawm stemcells hauv tib neeg lub cev yog qhov tsawg heev, uas tsis tuaj yeem ua raws li kev kho mob xav tau.

Lub 38th Society for Immunotherapy of Cancer (SITC) Lub Rooj Sab Laj Txhua Xyoo yuav muaj nyob rau lub Kaum Ib Hlis 1-5 hauv San Diego, Tebchaws Asmeskas.

Kev kho mob ntawm tes tau tsim kho sai heev nyob rau xyoo tas los no hauv kev tshawb fawb thiab kev tsim kho tshuaj, thiab yog tus qauv tsim tshuaj tshiab uas tau pom muaj peev xwm zoo hauv kev kho mob xws li mob qog noj ntshav, kab mob sib kis, thiab kab mob autoimmune.

Tsis ntev los no, Beijing T&L Biotechnology Ltd. (hu ua "T&L") ua tiav tau txais US FDA DMF sau npe rau nws cov CGT core raw khoom CD28 monoclonal antibody, nrog DMF sau npe 038820.

Tsis ntev los no, Beijing T&L Biotechnology Ltd. (tom qab no hu ua "T&L") tau txais tsab ntawv lees paub los ntawm US Food and Drug Administration (tom qab no hu ua "FDA"), hais tias lub tuam txhab cov ntaub ntawv tseem ceeb rau cov tshuaj kho cell, CD3 monoclonal antibody, thiab T cell sorting activation magnetic hlaws, US hom II tau ua tiav.